Track Atrys Health, S.A. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Atrys Health, S.A. ATRY.MC · Stock Open Atrys Health, S.A. in new tab

2.59 EUR
EPS
-0.63
P/B
1.32
ROE
-24.57
Beta
0.57
Target Price
4.83 EUR
Loading chart...
Key Metrics
Earnings dateMarch 3, 2027
EPS-0.63
Book Value1.94
Price to Book1.32
Debt/Equity80.29
% Insiders56.771%
Growth
Revenue Growth0.09%
Estimates
Forward P/E16.64
Forward EPS0.15
Target Mean Price4.83

DCF valuation

Model fair value for Atrys Health, S.A. (ATRY.MC)
Result
Sign in to run the valuation for ATRY.MC.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 4.83 EUR (low 4.00, high 5.50)
Low 4.00
Mean 4.83
High 5.50
Price 2.59
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Atrys Health, S.A. Logo Atrys Health, S.A. Analysis (ATRY.MC)

Spain Health Care Official Website Stock

Is Atrys Health, S.A. a good investment? Atrys Health, S.A. (ATRY.MC) is currently trading at 2.59 EUR. Market analysts have a consensus price target of 4.83 EUR. This suggests a potential upside from current levels.

Earnings Schedule: Atrys Health, S.A. is expected to release its next earnings report on March 3, 2027. The market consensus estimate for Forward EPS is 0.15.

Investor FAQ

Does Atrys Health, S.A. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Atrys Health, S.A.?

Atrys Health, S.A. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 3, 2027. The company currently has a trailing EPS of -0.63.

Company Profile

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Exchange Ticker
MCE (Spain) ATRY.MC
Trades
Dividend History paid per year (EUR)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 2, 2018 1.075
Oct. 30, 2019 1.014
Sept. 17, 2020 1:2
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion